Form 4: Sotera Health Director Receives Equity Grant

Director Kenneth D. Krause was granted 14,970 restricted stock units as part of the company's 2020 Omnibus Incentive Plan.

Summary

• Director Kenneth D. Krause acquired 14,970 restricted stock units (RSUs) on May 22, 2026.
• Each RSU represents a right to receive one share of common stock.
• The grant is subject to vesting conditions based on continued service as a non-employee director.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on the company's financial position.

Positives

• Alignment of director interests with shareholders through equity-based compensation.

Negatives

• Potential for future dilution of existing shareholders upon the vesting and issuance of the underlying common stock.

Risks

• Vesting is contingent upon the director's continued service, creating a dependency on personnel retention.

Future Outlook

The RSUs will vest in full on the earlier of the first anniversary of the grant date or the date immediately prior to the next regular annual shareholders meeting.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice to ensure long-term alignment with shareholder value in the healthcare services sector.

Comparison to Industry Standards

• The use of RSU grants for director compensation is consistent with standard practices for publicly traded companies of similar market capitalization.
• Vesting schedules tied to annual shareholder meetings are common in the industry to ensure board continuity.

Stakeholder Impact

• Minor potential dilution for existing shareholders upon future vesting.

Next Steps

• Vesting of the 14,970 RSUs on the earlier of May 22, 2027, or the date of the next annual shareholders meeting.

Key Dates

Keywords

Sotera Health, SHC, Director Compensation, Restricted Stock Units, Equity Grant, Insider Transaction